Iti Pharma And Healthcare Fund Overview
Category Sectoral/ Thematic
BMSMONEY Rank 5
BMSMONEY Rating
Gro. Opt. As On: 20-12-2024
NAV ₹17.04(R) -1.18% ₹18.17(D) -1.18%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 44.94% 20.91% -% -% -%
LumpSum (D) 47.69% 23.42% -% -% -%
SIP (R) -18.88% 27.19% -% -% -%
SIP (D) -17.2% 29.79% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.85 0.45 0.78 3.82% 0.14
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.13% -19.36% -16.09% 0.89 10.61%
Top Sectoral/ Thematic
Fund Name Rank Rating
Franklin India Opportunities Fund 1
Icici Prudential India Opportunities Fund 2
ICICI Prudential Business Cycle Fund 3
Icici Prudential Exports And Services Fund 4

NAV Date: 20-12-2024

Scheme Name NAV Rupee Change Percent Change
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 17.04
-0.2000
-1.1800%
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 17.04
-0.2000
-1.1800%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 18.17
-0.2200
-1.1800%
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option 18.17
-0.2200
-1.1800%

Review Date: 20-12-2024

ITI Pharma and Healthcare Fund has shown good performance in the Sectoral/ Thematic Fund category. The fund has rank of 5 out of 19 funds in the category. The fund has delivered return of 44.94% in 1 year and 20.91% in 3 years. The category average for the same periods is 25.16% and 18.2% respectively, which shows poor return performance of fund in the category. The fund has exhibited standard deviation of 15.13, VaR of -19.36, Average Drawdown of -7.55, Semi Deviation of 10.61 and Max Drawdown of -16.09. The category average for the same parameters is 14.03, -17.39, -5.79, 9.92 and -13.51 respectively. The fund has high risk in the category.
  • standard deviation of 15.13 and based on VaR one can expect to lose more than -19.36% of current value of fund in one year.
  • Sharpe ratio of the fund is 0.85 which shows good performance of fund in the sectoral/ thematic fund category.
  • The fund has R-square of 0.92, Beta of 0.89 and Jensen's Alpha of 3.82% which exhibit good performance in the sectoral/ thematic fund category .

  • Not able to see in mobile!!! save the chart by clicking on camera icon.

    KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 3.27
    2.79
    -3.13 | 8.71 8 | 30 Very Good
    3M Return % 1.14
    -6.29
    -15.75 | 2.79 2 | 28 Very Good
    6M Return % 22.09
    1.46
    -10.41 | 22.09 1 | 29 Very Good
    1Y Return % 44.94
    25.16
    11.27 | 48.83 2 | 25 Very Good
    3Y Return % 20.91
    18.20
    12.64 | 29.36 6 | 20 Good
    1Y SIP Return % -18.88
    -33.44
    -39.93 | -18.88 1 | 20 Very Good
    3Y SIP Return % 27.19
    18.42
    11.30 | 34.99 2 | 16 Very Good
    Standard Deviation 15.13
    14.03
    11.13 | 17.21 14 | 19 Average
    Semi Deviation 10.61
    9.92
    8.02 | 12.48 16 | 19 Poor
    Max Drawdown % -16.09
    -13.51
    -26.15 | -6.01 15 | 19 Average
    VaR 1 Y % -19.36
    -17.39
    -27.36 | -12.54 16 | 19 Poor
    Average Drawdown % -7.55
    -5.79
    -9.24 | -3.55 17 | 19 Poor
    Sharpe Ratio 0.85
    0.74
    0.15 | 1.49 7 | 19 Good
    Sterling Ratio 0.78
    0.80
    0.27 | 1.64 8 | 19 Good
    Sortino Ratio 0.45
    0.40
    0.10 | 0.82 7 | 19 Good
    Jensen Alpha % 3.82
    4.64
    -3.75 | 19.60 8 | 18 Good
    Treynor Ratio 0.14
    0.32
    0.05 | 3.84 7 | 18 Good
    Modigliani Square Measure % 22.05
    20.28
    10.99 | 48.11 7 | 18 Good
    Alpha % 1.75
    1.00
    -19.54 | 11.00 8 | 18 Good
    Return data last Updated On : Dec. 20, 2024.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % 3.42 2.89 -3.04 | 8.82 8 | 30
    3M Return % 1.60 -6.00 -15.50 | 3.14 2 | 28
    6M Return % 23.23 2.06 -9.85 | 23.23 1 | 29
    1Y Return % 47.69 26.61 11.63 | 50.62 2 | 25
    3Y Return % 23.42 19.56 13.74 | 30.60 6 | 20
    1Y SIP Return % -17.20 -32.53 -39.53 | -17.20 1 | 20
    3Y SIP Return % 29.79 19.92 12.56 | 36.51 2 | 16
    Standard Deviation 15.13 14.03 11.13 | 17.21 14 | 19
    Semi Deviation 10.61 9.92 8.02 | 12.48 16 | 19
    Max Drawdown % -16.09 -13.51 -26.15 | -6.01 15 | 19
    VaR 1 Y % -19.36 -17.39 -27.36 | -12.54 16 | 19
    Average Drawdown % -7.55 -5.79 -9.24 | -3.55 17 | 19
    Sharpe Ratio 0.85 0.74 0.15 | 1.49 7 | 19
    Sterling Ratio 0.78 0.80 0.27 | 1.64 8 | 19
    Sortino Ratio 0.45 0.40 0.10 | 0.82 7 | 19
    Jensen Alpha % 3.82 4.64 -3.75 | 19.60 8 | 18
    Treynor Ratio 0.14 0.32 0.05 | 3.84 7 | 18
    Modigliani Square Measure % 22.05 20.28 10.99 | 48.11 7 | 18
    Alpha % 1.75 1.00 -19.54 | 11.00 8 | 18
    Return data last Updated On : Dec. 20, 2024.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
    KPIs: Key Performance Indicators

    Investment Period Regular Direct
    Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
    1D -1.18 ₹ 9,882.00 -1.18 ₹ 9,882.00
    1W -0.03 ₹ 9,997.00 0.01 ₹ 10,001.00
    1M 3.27 ₹ 10,327.00 3.42 ₹ 10,342.00
    3M 1.14 ₹ 10,114.00 1.60 ₹ 10,160.00
    6M 22.09 ₹ 12,209.00 23.23 ₹ 12,323.00
    1Y 44.94 ₹ 14,494.00 47.69 ₹ 14,769.00
    3Y 20.91 ₹ 17,677.00 23.42 ₹ 18,799.00
    5Y
    7Y
    10Y
    15Y

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

    Investment Period Invested Amount Regular Direct
    XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
    1Y ₹ 12000 -18.88 ₹ 10,734.34 -17.20 ₹ 10,850.26
    3Y ₹ 36000 27.19 ₹ 53,316.76 29.79 ₹ 55,215.94
    5Y ₹ 60000
    7Y ₹ 84000
    10Y ₹ 120000
    15Y ₹ 180000


    Date Iti Pharma And Healthcare Fund NAV Regular Growth Iti Pharma And Healthcare Fund NAV Direct Growth
    20-12-2024 17.0379 18.1691
    19-12-2024 17.2416 18.3854
    18-12-2024 17.1567 18.2939
    17-12-2024 17.0431 18.1719
    16-12-2024 17.0968 18.2282
    13-12-2024 17.0429 18.1679
    12-12-2024 17.089 18.2161
    11-12-2024 17.2545 18.3916
    10-12-2024 17.1828 18.3143
    09-12-2024 17.195 18.3263
    06-12-2024 17.285 18.4193
    05-12-2024 17.3188 18.4544
    04-12-2024 17.289 18.4217
    03-12-2024 17.2439 18.3727
    02-12-2024 17.2481 18.3763
    29-11-2024 17.0996 18.2152
    28-11-2024 16.7446 17.8361
    27-11-2024 16.7807 17.8737
    26-11-2024 16.7859 17.8782
    25-11-2024 16.8508 17.9465
    22-11-2024 16.7257 17.8105
    21-11-2024 16.4991 17.5683

    Fund Launch Date: 17/Nov/2021
    Fund Category: Sectoral/ Thematic
    Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
    Fund Description: An open ended equity scheme investing in Pharma and Healthcare
    Fund Benchmark: Nifty Healthcare Total Return Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.